HOXA13 contributes to gastric carcinogenesis through DHRS2 interacting with MDM2 and confers 5‐FU resistance by a p53‐dependent pathway

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Molecular Carcinogenesis

• Publication date

  2018-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/mc.22793PMID 29436749
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.

  2018cited by this paper
• Oncogenic function of the homeobox A13-long noncoding RNA HOTTIP-insulin growth factor-binding protein 3 axis in human gastric cancer

  2016cited by this paper
• p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell lines

  2016cited by this paper
• HOTTIP and HOXA13 are oncogenes associated with gastric cancer progression.

  2016cited by this paper
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• Genetic variation of the ABC transporter gene ABCC1 (Multidrug resistance protein 1 – MRP1) in the Polish population

  2015cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance

  2015cited by this paper
• Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.

  2015cited by this paper
• Improving survival by exploiting tumor dependence on stabilized mutant p53 for treatment

  2015cited by this paper
• Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing

  2014cited by this paper
• Upregulation of Autophagy-Related Gene-5 (ATG-5) Is Associated with Chemoresistance in Human Gastric Cancer

  2014cited by this paper
• MDM2-p53 pathway in hepatocellular carcinoma.

  2014cited by this paper
• WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells

  2013cited by this paper
• The diagnosis and management of gastric cancer

  2013cited by this paper
• Identification and validation that up-expression of HOXA13 is a novel independent prognostic marker of a worse outcome in gastric cancer based on immunohistochemistry

  2013cited by this paper
• Gastric Cancer, Version 2.2013

  2013cited by this paper
• Cancer drug resistance: an evolving paradigm

  2013cited by this paper
• Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines.

  2013influential reference
• Characterization of amplification patterns and target genes on the short arm of chromosome 7 in early-stage lung adenocarcinoma.

  2013cited by this paper
• p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer.

  2012cited by this paper
• Combinatorial drug therapy for cancer in the post-genomic era

  2012cited by this paper
• Exploration of target genes of HOXA13 in esophageal squamous cell carcinoma cell line.

  2011cited by this paper
• Decreased Expression of RASSF6 Is a Novel Independent Prognostic Marker of a Worse Outcome in Gastric Cancer Patients after Curative Surgery

  2011cited by this paper
• Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer.

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• The HOX gene network in hepatocellular carcinoma

  2011cited by this paper
• 14-3-3γ Inhibition of MDMX-mediated p21 Turnover Independent of p53*

  2010cited by this paper
• Mitochondrial HEP27 Is a c-Myb Target Gene That Inhibits Mdm2 and Stabilizes p53

  2010cited by this paper
• Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma.

  2009cited by this paper
• HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer)

  2009cited by this paper
• TNM Classification of Malignant Tumours, 7th Edition

  2009cited by this paper
• Locally advanced and metastatic gastric cancer: current management and new treatment developments.

  2008cited by this paper
• Depsipeptide-resistant KU812 cells show reversible P-glycoprotein expression, hyper-acetylated histones, and modulated gene expression profile.

  2006cited by this paper
• The individualization of cancer therapy: the unexpected role of p53.

  2006cited by this paper
• Multidrug resistance‐associated protein (MRP1) gene is strongly expressed in gastric carcinomas. Analysis by immunohistochemistry and real‐time quantitative RT‐PCR

  2005cited by this paper
• MDM2 Is a Negative Regulator of p21WAF1/CIP1, Independent of p53*

  2004cited by this paper
• Changes in thymidylate synthase and its inhibition rate and changes in dihydropyrimidine dehydrogenase after the administration of 5-fluorouracil with cisplatin to nude mice with gastric cancer xenograft SC-1-NU

  2004cited by this paper
• Monochromosome transfer provides functional evidence for growth‐suppressive genes on chromosome 14 in nasopharyngeal carcinoma

  2003cited by this paper
• Chromosomal imbalances of primary and metastatic lung adenocarcinomas

  2002cited by this paper
• Multidrug resistance in cancer: role of ATP–dependent transporters

  2002cited by this paper
• Deregulated homeobox gene expression in cancer: cause or consequence?

  2002cited by this paper
• Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia

  2002cited by this paper
• Expression of multidrug resistance-related markers in gastric cancer.

  2000cited by this paper
• Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells.

  2000cited by this paper
• Deletions at 14q in malignant mesothelioma detected by microsatellite marker analysis

  1999cited by this paper
• Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53.

  1998cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• Regulation of p53 stability by Mdm2

  1997cited by this paper
• Identification of a novel nuclear protein synthesized in growth-arrested human hepatoblastoma HepG2 cells.

  1991cited by this paper
• Homeobox proteins as sequence-specific transcription factors.

  1988cited by this paper
• Tumor measurement in the nude mouse

  1986cited by this paper

• Targeting MDM2, RAS, and PCNA for cancer targeted therapy: pan-cancer approaches vs. cancer-specific strategies

  2025cites this paper
• BDH2 promotes GLIPR1 promoter methylation and thus increases 5-FU sensitivity in colorectal cancer.

  2025cites this paper
• MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future

  2024cites this paper
• A comprehensive characterization of the dehydrogenase-reductase DHRS2 and its involvement in histone deacetylase inhibition.

  2024cites this paper
• Auxiliary Diagnosis and Prognostic Value of Dehydrogenase/Reductase 2 (DHRS2) in Various Tumors

  2023cites this paper
• Hsa-microRNA-1249-3p/Homeobox A13 axis modulates the expression of β-catenin gene in human epithelial cells

  2023cites this paper
• HOXA13 promotes the proliferation, migration, and invasion of nasopharyngeal carcinoma HNE1 cells by upregulating the expression of Snail and MMP-2

  2023cites this paper
• STAMBPL1 promotes the progression of lung adenocarcinoma by inhibiting DHRS2 expression

  2023cites this paper
• DHRS2 inhibits cell growth and metastasis in ovarian cancer by downregulation of CHKα to disrupt choline metabolism

  2022cites this paper
• Gene Structure Evolution of the Short-Chain Dehydrogenase/Reductase (SDR) Family

  2022cites this paper
• HOXA13 serves as a biomarker to predict neoadjuvant therapy efficacy in advanced colorectal cancer patients

  2022cites this paper
• Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells

  2022cites this paper
• Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts

  2021cites this paper
• Coexpression of HOXA6 and PBX2 promotes metastasis in gastric cancer

  2021cites this paper
• Emerging roles of dehydrogenase/reductase member 2 (DHRS2) in the pathology of disease.

  2021cites this paper
• Homeobox-A13 acts as a functional prognostic and diagnostic biomarker via regulating P53 and Wnt signaling pathways in lung cancer

  2021cites this paper
• Co-Delivery of Paclitaxel and shMCL-1 by Folic Acid-Modified Nonviral Vector to Overcome Cancer Chemotherapy Resistance.

  2021cites this paper
• HOXA13, Negatively Regulated by miR-139-5p, Decreases the Sensitivity of Gastric Cancer to 5-Fluorouracil Possibly by Targeting ABCC4

  2021cites this paper
• Impact of Reactive Oxygen and Nitrogen Species Produced by Plasma on Mdm2–p53 Complex

  2021cites this paper
• Molecular implications of HOX genes targeting multiple signaling pathways in cancer

  2021cites this paper
• DHRS2 is a potential marker of breast cancer metastasis

  2021cites this paper
• Identifying the Predictive Role of Oxidative Stress Genes in the Prognosis of Glioma Patients

  2021cites this paper
• HSF1 Regulates Cellular Senescence: Role of the DHRS2-MDM2-p53 Pathway

  2020cites this paper
• Decreased DHRS2 expression is associated with HDACi resistance and poor prognosis in ovarian cancer

  2020cites this paper
• Downregulated long noncoding RNA LUCAT1 inhibited proliferation and promoted apoptosis of cardiomyocyte via miR-612/HOXA13 pathway in chronic heart failure.

  2020cites this paper
• Forced expression of HOXA13 confers oncogenic hallmarks to esophageal keratinocytes.

  2020cites this paper
• Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma

  2020cites this paper
• Up-regulation of hypoxia-inducible factor antisense as a novel approach to treat ovarian cancer

  2020cites this paper
• LEF1 Induces DHRS2 Gene Expression in Human Acute Leukemia Jurkat T-Cells

  2020cites this paper
• HOXA13 promotes colon cancer progression through β-catenin-dependent WNT pathway.

  2020cites this paper
• LEF 1 induces DHRS 2 gene expression in human acute leukemia

  2020cites this paper
• Homeobox proteins are potential biomarkers and therapeutic targets in gastric cancer: a systematic review and meta-analysis

  2020cites this paper
• Ubiquitin–proteasome system (UPS) as a target for anticancer treatment

  2020cites this paper
• Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction

  2019cites this paper
• EMT is associated with an epigenetic signature of ECM remodeling genes

  2019cites this paper
• Molecular mechanism of resistance to chemotherapy in gastric cancers, the role of autophagy.

  2019cites this paper
• The role of MDM2 amplification and overexpression in therapeutic resistance of malignant tumors

  2019cites this paper
• Dehydrogenase/reductase SDR family member 2 silencing sensitizes an oxaliplatin-resistant cell line to oxaliplatin by inhibiting excision repair cross-complementing group 1 protein expression

  2019cites this paper
• Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells

  2019cites this paper
• DHRS2 mediates cell growth inhibition induced by Trichothecin in nasopharyngeal carcinoma

  2019cites this paper
• Paralogous HOX13 Genes in Human Cancers

  2019cites this paper
• Towards the overcoming of anticancer drug resistance mediated by p53 mutations.

  2019cites this paper
• Identification of key genes involved in type 2 diabetic islet dysfunction: a bioinformatics study

  2019cites this paper
• Long noncoding RNA LUCAT1 promotes malignancy of ovarian cancer through regulation of miR-612/HOXA13 pathway.

  2018cites this paper
• Increased DHRS12 expression independently predicts poor survival in patients with high-grade serous ovarian cancer.

  2018cites this paper
• Mechanisms and relevant genes of drug resistance in gastric cancer

  2018cites this paper